285 related articles for article (PubMed ID: 31322274)
1. Low lncRNA ZNF385D‑AS2 expression and its prognostic significance in liver cancer.
Zhang Z; Wang S; Liu Y; Meng Z; Chen F
Oncol Rep; 2019 Sep; 42(3):1110-1124. PubMed ID: 31322274
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer.
Zhang Z; Wang S; Yang F; Meng Z; Liu Y
Oncol Rep; 2020 Jan; 43(1):55-74. PubMed ID: 31746401
[TBL] [Abstract][Full Text] [Related]
3. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
Jiao Y; Li Y; Ji B; Cai H; Liu Y
J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
[TBL] [Abstract][Full Text] [Related]
5. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma.
Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z
J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123
[TBL] [Abstract][Full Text] [Related]
6. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma.
Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ
Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
10. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
Wang B; Tang D; Zhang Z; Wang Z
J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
12. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
13. A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients.
Jiang H; Zhao L; Chen Y; Sun L
J Clin Lab Anal; 2020 Sep; 34(9):e23377. PubMed ID: 32474975
[TBL] [Abstract][Full Text] [Related]
14. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
15. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y
Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
17. Five lncRNAs associated with the survival of hepatocellular carcinoma: a comprehensive study based on WGCNA and competing endogenous RNA network.
Liu DH; Wang SL; Hua Y; Shi GD; Qiao JH; Wei H
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7621-7633. PubMed ID: 32744688
[TBL] [Abstract][Full Text] [Related]
18. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Wang J; Pu J; Yao T; Lu X; Deng Y
J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]